Hysteroscopic female sterilization with Essure in an outpatient setting.
The aim of this study is to evaluate the short and long-term results of hysteroscopic sterilization in an outpatient setting. Sixty-one women underwent hysteroscopic sterilization. At follow-up, all of the women were asked to complete a questionnaire concerning possible pregnancy, bleeding patterns, side-effects, or need for further therapy after sterilization. Technical feasibility, complications, patient satisfaction, and tubal occlusion based on X-ray or ultrasound were measured. Fifty-eight (95%) women were sterilized according to this method. Successful bilateral device placement was achieved in 52 women (85%) during the first attempt and in six (9.8%) during the second. A total of 50 (81.9%) women submitted completed outcome questionnaires. The mean follow-up period was 23 (range 7-67) months. No pregnancies were reported. All questionnaire respondents expressed overall satisfaction with the procedure. To conclude, Essure sterilization is a safe effective method for female sterilization that is feasible in the outpatient setting.
Department of Clinical Science, Division of Obstetrics and Gynecology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden.
Sonia
S
Andersson
Sofie
S
Eriksson
Miriam
M
Mints
D000328:Adult; D000556:Ambulatory Surgical Procedures; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D008875:Middle Aged; D013245:Sterilization, Reproductive / Q000295:instrumentation*; D011795:Surveys and Questionnaires